Two federal judges issued conflicting rulings around medication abortion Friday, creating even greater turmoil amid dwindling abortion rights in the U.S. In Texas, a Trump-appointed judge placed a nationwide injunction on the FDA’s approval of mifepristone — issued over two decades ago — which is due to take effect at the end of this week. The Justice Department is appealing the ruling. Meanwhile, in a separate case, a Washington state judge ordered the FDA not to make any changes to mifepristone’s availability. After headlines, we’ll spend the rest of the hour looking at the implications of these rulings.
Fate of Medication Abortion in Legal Limbo as Two U.S. Judges Issue Conflicting Rulings
HeadlineApr 10, 2023